Tributyltin Protumorigenic Effects Targeting Prostate Cancer Cell Metabolism, Proliferation, Migration, and Invasion
Environmental Toxicology · 2026
DOI: 10.1002/tox.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2026. Verfasst von Mariana Feijó und 9 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Covilhã, Portugal. Hauptthemen laut MEDLINE: Trialkyltin Compounds, Prostatic Neoplasms, Endocrine Disruptors. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação para a Ciência e a Tecnologia, European Regional Development Fund.
Abstract (Originalsprache)
Prostate cancer (PCa) is an endocrine‐related cancer highly dependent on androgenic signaling. Beyond hormone dependence, extrinsic factors play a significant role in the risk of developing PCa, which raises concern about the influence of environmental compounds such as endocrine‐disrupting chemicals (EDCs). Tributyltin (TBT) is an EDC used in antifouling paints, and its androgenic (and obesogenic) actions have been described. This study investigated the effect of TBT on various cancer hallmarks, specifically its impact on the viability, metabolism, proliferation, migration, and invasion of prostate cells, using in vitro and in vivo models. Androgen‐sensitive (LNCaP) and androgen‐insensitive (PC3) PCa cells were exposed to 1–100 nM TBT for 24 and 48 h. Additionally, LNCaP cells were treated with 100 nM TBT in the presence of the androgen receptor antagonist bicalutamide (1–40 μM) or 10 nM TBT and/or low‐density lipoprotein (LDL, 100 μg/mL) and 5α‐dihydrotestosterone (DHT, 10 nM, 48 h). Wistar rats were administered TBT (50 μg/kg) every 3 days for 45 days. TBT disrupted glycolytic flux and lipid handling in prostate cells, enhancing their proliferative activity. Moreover, 100 nM TBT stimulated migration and invasion of LNCaP cells. Bicalutamide attenuated the effect of TBT in inducing glucose consumption and LNCaP cell proliferation. A 10× lower TBT concentration maintained the stimulatory effects on LNCaP cells' viability, proliferation, and migration/invasion, sustained by high LDL‐cholesterol availability and DHT. Our results show TBT as a potential inducer of PCa progression and aggressiveness and contribute to increasing awareness about the roles of EDCs in the prostate carcinogenic process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Covilhã, Portugal.
- RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Instituto Português de Oncologia de Coimbra Francisco Gentil, Coimbra, Portugal.
ORCID-Profile: Sílvia Socorro
Förderung
- Fundação para a Ciência e a Tecnologia
- European Regional Development Fund
Zitieren
APA
Feijó, M., Brás, L. P., Serra, C. M. D., Fonseca, L. R. S., Correia, S., Pereira, B. J., Duarte, A. P., Cardoso, H. J., Vaz, C. V., & Socorro, S. (2026). Tributyltin Protumorigenic Effects Targeting Prostate Cancer Cell Metabolism, Proliferation, Migration, and Invasion. Environmental Toxicology. https://doi.org/10.1002/tox.70029
Vancouver
Feijó M, Brás LP, Serra CMD, Fonseca LRS, Correia S, Pereira BJ, et al. Tributyltin Protumorigenic Effects Targeting Prostate Cancer Cell Metabolism, Proliferation, Migration, and Invasion. Environmental Toxicology. 2026. doi:10.1002/tox.70029
BibTeX
@article{Feij2026,
author = {Feijó, Mariana and Brás, Luís P and Serra, Catarina M D and Fonseca, Lara R S and Correia, Sara and Pereira, Bruno J and Duarte, Ana P and Cardoso, Henrique J and Vaz, Cátia V and Socorro, Sílvia},
title = {Tributyltin Protumorigenic Effects Targeting Prostate Cancer Cell Metabolism, Proliferation, Migration, and Invasion},
journal = {Environmental Toxicology},
year = {2026},
doi = {10.1002/tox.70029}
}
EUVIMED